Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05255705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Barts Revascularisation Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Mar 1, 2026 → Mar 30, 2030
See other at-risk trials from Queen Mary University of London

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Mar 1, 2026 to Mar 30, 2030
    • Eligibility criteria expanded, about 6 words
  2. Re-verified, no change to tracked fieldsv5
  3. Start date: Dec 1, 2022 to Aug 6, 2021v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 1, 2022 to Dec 1, 2022
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide. This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.
Trial Details
NCT Number NCT05255705
Lead Sponsor Queen Mary University of London
Conditions
(from sponsor)		 Myocardial Infarction, Stable Angina
Related terms Angina, Stable, Myocardial Infarction
Enrollment 20,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov